+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Emergent BioSolutions, Inc. - logo

Emergent BioSolutions manufactures immunobiotics such as vaccines and immune globulins that assist the body’s immune system. The company’s biodefense segment develops drugs such as BioThrax, a vaccine for the prevention of anthrax, for use against biological agents. Other products in preclinical development include drugs for the treatment of patients exposed to anthrax and botulinum toxin. The company, which was founded in 1998, is based in Rockville, Maryland.

From
Intravenous Immunoglobulin Global Market Report 2024 - Product Thumbnail Image

Intravenous Immunoglobulin Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Immunoglobulins Global Market Report 2024 - Product Thumbnail Image

Immunoglobulins Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
From
Diphtheria Global Market Report 2024 - Product Thumbnail Image

Diphtheria Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Influenza Vaccine Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Influenza Vaccine Market - Forecasts from 2022 to 2027

  • Report
  • March 2022
  • 124 Pages
  • Global
From
From
From
Dengue - Pipeline Insight, 2024 - Product Thumbnail Image

Dengue - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Influenza - Pipeline Insight, 2024 - Product Thumbnail Image

Influenza - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 280 Pages
  • Global
From
Loading Indicator